NCT05009368 - A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

October 8, 2021

Study Completion Date

October 15, 2021

Conditions

Health, Subjective

Interventions

DRUG

Drug: Treatment A

CTL0901, single dose, daily, repeated oral administration for 4 days

DRUG

Drug: Treatment B

CTL0902, single dose, daily, repeated oral administration for 7 days

DRUG

Drug: Treatment C

CTL0901 and CTL0902, single dose, daily, repeated oral administration for 7 days

Trial Locations (1)

H Plus Yangji Hospital, Seoul